Transcatheter Embolization and Occlusion Devices Market

Transcatheter Embolization and Occlusion Devices Market contains market size and forecasts of Transcatheter Embolization and Occlusion Devices in global, including the following market information:
Global Transcatheter Embolization and Occlusion Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Transcatheter Embolization and Occlusion Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Transcatheter Embolization and Occlusion Devices companies in 2021 (%)
The global Transcatheter Embolization and Occlusion Devices market was valued at 3534.7 million in 2021 and is projected to reach US$ 5152.6 million by 2028, at a CAGR of 5.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Embolization Coils Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transcatheter Embolization and Occlusion Devices include Abbott, AtriCure, Boston Scientific Corporation, CeloNova, Medtronic, Cook Medica, Cordis, DePuy Synthes and Direct Flow, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transcatheter Embolization and Occlusion Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transcatheter Embolization and Occlusion Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transcatheter Embolization and Occlusion Devices Market Segment Percentages, by Type, 2021 (%)
Embolization Coils
Coiling-assist Devices
Flow-diverting Devices
PV Embolization Coil
PV Plugs
Embolization Particles
Liquid Embolics
Accessories
Global Transcatheter Embolization and Occlusion Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transcatheter Embolization and Occlusion Devices Market Segment Percentages, by Application, 2021 (%)
Civil Household
Commercial(Cold Storage/Building etc)
Environmental Monitoring
Chemical
Automobile
Global Transcatheter Embolization and Occlusion Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transcatheter Embolization and Occlusion Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transcatheter Embolization and Occlusion Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Transcatheter Embolization and Occlusion Devices revenues share in global market, 2021 (%)
Key companies Transcatheter Embolization and Occlusion Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Transcatheter Embolization and Occlusion Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
AtriCure
Boston Scientific Corporation
CeloNova
Medtronic
Cook Medica
Cordis
DePuy Synthes
Direct Flow
Edwards
Eisai
Marine Polymer
Terumo Corporation
Medtronic, Inc.
Merit Medical System
Stryker Corporation
Abbott
Pfizer, Inc.
Sirtex medical
Nordian